Management of dyslipidemia in pediatric renal transplant recipients.

Autor: Bock ME; Section of Pediatric Nephrology, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA., Wall L; Clinical Nutrition Department, Children's Hospital Colorado, Aurora, CO, USA., Dobrec C; Clinical Nutrition Department, Children's Hospital Colorado, Aurora, CO, USA., Chandran M; Pharmacy Department, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA., Goebel J; Section of Pediatric Nephrology, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA. jens.goebel@childrenscolorado.org.
Jazyk: angličtina
Zdroj: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2021 Jan; Vol. 36 (1), pp. 51-63. Date of Electronic Publication: 2020 Jan 02.
DOI: 10.1007/s00467-019-04428-y
Abstrakt: Dyslipidemia after kidney transplantation is a common complication that has historically been underappreciated, especially in pediatric recipients. It is also a major modifiable risk factor for cardiovascular disease, a top cause of morbidity and mortality of transplant patients. While most knowledge about post-transplant dyslipidemia has been generated in adults, recommendations and treatment strategies also exist for children and are presented in this review. Awareness of these applicable guidelines and approaches is required, but not sufficient, for the reliable management of dyslipidemia in our patients, and additional needs and opportunities for comprehensive care in this area (e.g., quality improvement) are outlined.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje